KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Return on Capital Employed (2016 - 2025)

Ionis Pharmaceuticals (IONS) has 16 years of Return on Capital Employed data on record, last reported at 0.13% in Q3 2025.

  • For Q3 2025, Return on Capital Employed fell 10.0% year-over-year to 0.13%; the TTM value through Sep 2025 reached 0.13%, down 10.0%, while the annual FY2024 figure was 0.18%, 15.0% down from the prior year.
  • Return on Capital Employed reached 0.13% in Q3 2025 per IONS's latest filing, up from 0.13% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.01% in Q3 2022 and bottomed at 0.22% in Q3 2023.
  • Average Return on Capital Employed over 5 years is 0.09%, with a median of 0.04% recorded in 2024.
  • Peak YoY movement for Return on Capital Employed: dropped -23bps in 2023, then increased 18bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.01% in 2021, then tumbled by -1326bps to 0.19% in 2022, then soared by 85bps to 0.03% in 2023, then tumbled by -523bps to 0.17% in 2024, then grew by 24bps to 0.13% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.13% in Q3 2025, 0.13% in Q2 2025, and 0.18% in Q1 2025.